Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-35.79	16.76	26.10
Graham Fair Price	44.97	12641.57	8720.25
PEG	-77.27	-0.02	0.09
Price/Book	8.96	0.55	0.50
Price/Cash Flow	232.57	-22.57	6.79
Prices/Earnings	-47.47	6.54	-12.45
Price/Sales	19.44	1.20	1.00
Price/FCF	232.57	-22.57	6.79
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	10.58	0.23	0.20
Operating Margin	191.07	0.05	0.02
ROA	110.29	0.01	< 0.005
ROE	-0.01	0.02	107.42
ROIC	< 0.005	0.02	116.04
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.20	-0.04	-358.15
Dividends QOQ	-0.99	308.60	31033.78
EBIT QOQ	-0.77	1.67	116.76
EPS QOQ	-1.34	3.09	131.14
FCF QOQ	18.29	-1.33	-92.73
Revenue QOQ	-0.04	-0.08	-110.40
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.11	54.46	26.34
Days Sales Outstanding (DSO)	73.92	86.05	16.42
Inventory Turnover	2.09	1.65	-20.85
Debt/Capitalization	0.18	0.15	-17.58
Quick Ratio	1.17	1.11	-4.67
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	18290.42	18410.56	0.66
Cash	4410.26	3157.84	-28.40
Capex	-235.60	-137.30	41.72
Free Cash Flow	1355.56	-447.03	-67.02
Revenue	9182.33	8431.87	-8.17
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.52	1.52	-0.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.99	0.15	-84.60
Naive Interpretation	Member

06 - Financial Health · Weak

Rating